Literature DB >> 33010333

Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.

Jafrin Jobayer Sonju1, Achyut Dahal1, Sitanshu S Singh1, Seetharama D Jois2.   

Abstract

Clinically efficacious medication in anticancer therapy has been successfully designed with liposome-based nanomedicine. The liposomal formulation in cancer drug delivery can be facilitated with a functionalized peptide that mediates the specific drug delivery opportunities with increased drug penetrability, specific accumulation in the targeted site, and enhanced therapeutic efficacy. This review aims to focus on recent advances in peptide-functionalized liposomal formulation techniques in cancer diagnosis and treatment regarding recently published literature. It also will highlight different aspects of novel liposomal formulation techniques that incorporate surface functionalization with peptides for better anticancer effect and current challenges in peptide-functionalized liposomal drug formulation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Peptide; active targeting; bio-nanoparticle; cancer; diagnostic liposomes; liposome; nanotechnology; peptide-functionalized liposome

Mesh：

Substances：

Year:  2020        PMID： 33010333      PMCID： PMC8082750          DOI： 10.1016/j.jconrel.2020.09.055

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


  171 in total

1.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.

Authors:  Lin Zhu; Pooja Kate; Vladimir P Torchilin
Journal:  ACS Nano       Date:  2012-03-14       Impact factor: 15.881

2.  Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.

Authors:  Fei Yan; Song Wang; Wei Yang; S Nahum Goldberg; Hao Wu; Wan-Lu Duan; Zhi-Ting Deng; Hai-Bo Han; Hai-Rong Zheng
Journal:  Radiology       Date:  2017-06-19       Impact factor: 11.105

3.  Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model.

Authors:  P M Alderton; J Gross; M D Green
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

Review 4.  Drug targeting strategies in cancer treatment: an overview.

Authors:  J L Arias
Journal:  Mini Rev Med Chem       Date:  2011-01       Impact factor: 3.862

Review 5.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

6.  Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery.

Authors:  Min Hyung Kang; Hyun Joon Yoo; Yie Hyuk Kwon; Ho Yub Yoon; Sang Gon Lee; Sung Rae Kim; Dong Woo Yeom; Myung Joo Kang; Young Wook Choi
Journal:  Mol Pharm       Date:  2015-11-06       Impact factor: 4.939

7.  Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.

Authors:  Zhen-Zhen Yang; Jing-Quan Li; Zhan-Zhang Wang; Da-Wen Dong; Xian-Rong Qi
Journal:  Biomaterials       Date:  2014-03-30       Impact factor: 12.479

8.  P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.

Authors:  Sheida Shariat; Ali Badiee; Seyed Amir Jalali; Mercedeh Mansourian; Mona Yazdani; Seyed Alireza Mortazavi; Mahmoud Reza Jaafari
Journal:  Cancer Lett       Date:  2014-09-16       Impact factor: 8.679

9.  Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.

Authors:  Pranali Deshpande; Aditi Jhaveri; Bhushan Pattni; Swati Biswas; Vladimir Torchilin
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging.

Authors:  Yin Song; Wei Li; Shuyan Meng; Wei Zhou; Bo Su; Liang Tang; Yinmin Zhao; Xiaoyan Wu; Dazhi Yin; Mingxia Fan; Caicun Zhou
Journal:  Nanoscale Res Lett       Date:  2018-11-27       Impact factor: 4.703
View more
  12 in total

Review 1.  Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy.

Authors:  Valentina Foglizzo; Serena Marchiò
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 2.  Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy.

Authors:  Marcela Tavares Luiz; Jessyca Aparecida Paes Dutra; Larissa Bueno Tofani; Jennifer Thayanne Cavalcante de Araújo; Leonardo Delello Di Filippo; Juliana Maldonado Marchetti; Marlus Chorilli
Journal:  Pharmaceutics       Date:  2022-04-08       Impact factor: 6.525

3.  A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer.

Authors:  Jafrin Jobayer Sonju; Achyut Dahal; Sitanshu S Singh; Xin Gu; William D Johnson; Chandra Mohan Reddy Muthumula; Sharon A Meyer; Seetharama D Jois
Journal:  Int J Pharm       Date:  2021-12-09       Impact factor: 6.510

Review 4.  Surface Engineering of Nanomaterials with Polymers, Biomolecules, and Small Ligands for Nanomedicine.

Authors:  Ana M Díez-Pascual
Journal:  Materials (Basel)       Date:  2022-04-30       Impact factor: 3.748

Review 5.  Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

Authors:  Gan Luo; Jue Zhang; Yaqi Sun; Ya Wang; Hanbin Wang; Baoli Cheng; Qiang Shu; Xiangming Fang
Journal:  Nanomicro Lett       Date:  2021-03-08

6.  Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy.

Authors:  Ning Zhang; Yibin Wu; Weiqi Xu; Zhenjian Li; Lu Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 7.  Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.

Authors:  Haijie Han; Su Li; Yueyang Zhong; Yue Huang; Kai Wang; Qiao Jin; Jian Ji; Ke Yao
Journal:  Asian J Pharm Sci       Date:  2021-07-01       Impact factor: 6.598

Review 8.  Advanced Peptide Nanomedicines for Bladder Cancer Theranostics.

Authors:  Sheng Zeng; Xiaodi Feng; Shaoqiang Xing; Zhaoliang Xu; Zhizhao Miao; Qian Liu
Journal:  Front Chem       Date:  2022-08-05       Impact factor: 5.545

9.  Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis.

Authors:  Zhiwei Zhang; Lixin Ma; Jingwen Luo
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

10.  Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy.

Authors:  Himgauri Naik; Jafrin Jobayer Sonju; Sitanshu Singh; Ioulia Chatzistamou; Leeza Shrestha; Ted Gauthier; Seetharama Jois
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.